| 出品公司: | ATCC |
|---|---|
| 菌种名称: | ATCC10060 ATCC10060 |
| 菌种又名: | NRRL 315 [4656, CBS 536.65, IFO 7538, IMI 51982, QM 1885, WB 315] |
| 菌株类型: | 洋葱曲霉Aspergillus alliaceus |
| 存储人: | NRRL |
| 分离来源: | 死水疱甲虫 |
| 产品目录号: | 10060 |
| 培养基: | ATCC培养基325：麦芽提取物琼脂（Blakeslee公式） |
| 生长条件: | 24 ℃ |
| 生物安全等级: | 1 |
| 模式菌株: | 否 |
| 应用: | 科研，生产，主要用于黄酮类化合物的转化 |
| 菌株特点: |
ATCC10060 洋葱曲霉Aspergillus alliaceus |
| 参考文献: |
Goetz MA, et al. Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties. J. Antibiot. 38: 1633-1637, 1985. PubMed: 3005212
Ibrahim AR, Abul-Hajj YJ. Microbiological transformation of flavone and isoflavone. Xenobiotica 20: 363-373, 1990. PubMed: 2346033
Formisyn P, et al. Biotransformation by fungi: oxidation of ellipticine into 9-hydroxy-ellipticine by an Aspergillus alliaceus strain CBS 536.65. Lett. Appl. Microbiol. 19: 244-246, 1994.
Laakso JA, et al. Isokotanins A-C: new bicoumarins from the sclerotia of Aspergillus alliaceus. J. Nat. Prod. 57: 128-133, 1994. PubMed: 8158157
Chien MM, Rosazza JP. Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxy-ellipticines. Drug Metab. Dispos. 7: 211-214, 1979. PubMed: 39722
|
买家导航
